Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 9/20 | 0.62 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | GLP1R | P43220 | 4/20 | 0.56 |
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.55 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262193 | 0.93 | PTH1R (0.64) | PTH1RKEAP1GLP1RCALCR | |
| SCHEMBL30567726 | 0.90 | GLP1R (0.58) | PTH1RKEAP1GLP1RCALCRCRHR1 | |
| SCHEMBL31190181 | 0.90 | PTH1R (0.61) | PTH1RGLP1R | |
| SCHEMBL29586748 | 0.90 | KEAP1 (0.66) | PTH1RKEAP1GLP1RCALCRCRHR1 | |
| SCHEMBL31182441 | 0.90 | GLP1R (0.66) | KEAP1GLP1RCALCRCRHR1CRHR2 | |
| SCHEMBL31182663 | 0.89 | CALCR (0.63) | PTH1RKEAP1GLP1RCALCRCRHR1 | |
| Teriparatide SCHEMBL30645329 | 0.89 | PTH1R (0.80) | PTH1RKEAP1GLP1R | |
| SCHEMBL30176478 | 0.89 | PTH1R (0.62) | PTH1RGLP1RCALCRCRHR1CRHR2 | |
| SCHEMBL30529017 | 0.89 | PTH1R (0.65) | PTH1RKEAP1GLP1RCALCRCRHR1 | |
| SCHEMBL30979202 | 0.89 | GLP1R (0.64) | PTH1RKEAP1GLP1RCALCRCRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-116785403-A | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |